Neoadjuvant chemotherapy in palpable breast cancer: evaluation of physiologic, radiologic and molecular markers in predicting response.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Doxorubicin; Paclitaxel
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- 10 Apr 2017 Biomarkers information updated
- 07 May 2012 Actual patient number is 62 according to ClinicalTrials.gov.
- 07 May 2012 Planned end date changed from 30 May 2004 to 1 Mar 2005 as reported by ClinicalTrials.gov.